Gliomatosis cerebri treatment in 11 elderly patients

M. Piccirilli, A. Landi, M. Salvati

Research output: Contribution to journalArticlepeer-review


The Authors report their experience in the treatment of eleven patients over 70 years old (range from 70 to 83, average age 74.8, 7 males and 4 females), with histologically proven diagnosis of glioblastoma multiforme. The GC golden standard treatment is still debated, particularly in elderly patients. All the patients underwent a first line treatment with chemotherapy (Temozolomide), followed by Whole Brain Radiotherapy (WBRT) and PCV schedule without Vincristine in case of progression of the disease. The median survival was 16.3 months, ranging from 13 to 22 months. According to our experience, elderly patients should undergo the same treatment of younger patients, provided they are in good health conditions.

Original languageEnglish
Pages (from-to)183-187
Number of pages5
JournalJournal of Experimental and Clinical Cancer Research
Issue number2
Publication statusPublished - Jun 2006


  • Elderly patients
  • Gliomatosis cerebri
  • Magnetic resonance imaging

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Gliomatosis cerebri treatment in 11 elderly patients'. Together they form a unique fingerprint.

Cite this